Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | 4-Methylpyrazole | HCID 3406 | — |
| Reactant | HCID 86622620 | HCID 86622620 | — |
| Reactant | HCID 86622805 | HCID 86622805 | — |
| Reactant | HCID 131729449 | HCID 131729449 | — |
| Product | HCID 131729448 | HCID 131729448 | — |
Reaction Steps
The title compound is prepared by an analogous procedure to 1R,2S,3R,5S)-3-[2-Chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-5-(4-methyl-pyrazol-1-yl)-cyclopentane-1,2-diol (Intermediate BA1) by replacing Carbonic acid (1S,4R)-4-[2-chloro-6-(2,2-diphenyl-ethylamino)-purin-9-yl]-cyclopent-2-enyl ester ethyl ester (Intermediate AA) in step 1 with Carbonic acid (1S,4R)-4-(6-{[bis-(4-methoxy-phenyl)-methyl]-amino}-2-chloro-purin-9-yl)-cyclopent-2-enyl ester ethyl ester (Intermediate AB) and by replacing 4-methylpyrazole with 4-(tert-Butyl-diphenyl-silanyloxymethyl)-1H-pyrazole. 1H nmr (CDCl3, 400 MHz); 7.70 (m, 4H), 7.50-7.20 (m, 13H), 6.85 (m, 4H), 6.60 (s, 1H), 5.60 (s, 1H), 4.80 (m, 1H), 4.70 (m, 4H), 4.30 (m, 1H), 3.80 (s, 6H), 3.00 (m, 1H), 2.70 (m, 1H), 1.10 (s, 9H).
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08114877B2 |
|---|
| Source dataset | uspto-grants-2012_02 |
|---|
| ORD ID | ord-0b5d9292482c425ba8df1c24461c46d7 |
|---|
| Source note | uspto-grants-2012_02 |
|---|